Enlightenment Research, LLC Merck & Co., Inc. Transaction History

Enlightenment Research, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $743,864 - $835,648	8,800 New	8,800 $758,000
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $610,133 - $683,920	-8,300 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $599,924 - $751,482	8,300 New	8,300 $636,000
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $316,395 - $349,965	-4,500 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$68.86 - $81.11 $309,870 - $364,995	4,500 New	4,500 $347,000
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $219,540 - $248,850	-3,000 Closed	0 $0
Q2 2020 Aug 06, 2020	SELL	$70.42 - $80.13 $204,218 - $232,377	-2,900 Reduced 49.15%	3,000 $232,000
Q1 2020 May 08, 2020	BUY	$63.36 - $87.82 $373,824 - $518,137	5,900 New	5,900 $452,000
Q4 2019 Feb 11, 2020	SELL	$77.58 - $87.54 $411,174 - $463,962	-5,300 Closed	0 $0
Q3 2019 Oct 16, 2019	SELL	$76.08 - $82.93 $304,320 - $331,720	-4,000 Reduced 43.01%	5,300 $446,000
Q2 2019 Aug 05, 2019	SELL	$69.84 - $81.59 $58,456 - $68,290	-837 Reduced 8.26%	9,300 $737,000
Q1 2019 May 03, 2019	BUY	$69.58 - $79.36 $610,842 - $696,701	8,779 Added 646.47%	10,137 $843,000
Q4 2018 Feb 06, 2019	BUY	$65.24 - $75.71 $88,595 - $102,814	1,358 New	1,358 $104,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Enlightenment Research, LLC, based on Form 13F filings with the SEC.

Stay updated on Enlightenment Research, LLC with notifications on news.